Prolongation of the antidepressant response to partial sleep deprivation by lithium. 1986

L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze

Depressed patients given a loading dose of lithium on the first of 2 successive days of partial sleep deprivation (PSD), and kept at maintenance levels thereafter, showed significantly greater prolongation of the antidepressant effects of PSD than patients treated with PSD and placebo, even though the acute elevation in mood derived from PSD was as great on placebo as on lithium. Depression was assessed 3 days after PSD with an augmented version of the Hamilton Rating Scale for Depression. Patients on lithium alone, without PSD, did not have the acute elevation in mood seen in the two PSD groups and had significantly less improvement in depression than those who received PSD with lithium.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
May 1994, Biological psychiatry,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
August 1990, The American journal of psychiatry,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
April 2008, Journal of clinical psychopharmacology,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
January 2006, Psychiatry research,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
June 1985, Archives of general psychiatry,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
January 2008, Depression and anxiety,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
March 1984, Biological psychiatry,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
April 1995, Biological psychiatry,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
August 2007, Journal of affective disorders,
L R Baxter, and E H Liston, and J M Schwartz, and L L Altshuler, and J N Wilkins, and S Richeimer, and B H Guze
May 1990, Psychiatry research,
Copied contents to your clipboard!